2023 Department of Pediatrics Academic Annual Report

GRANTS AWARDED IN 2023 (continued)

INVESTIGATOR PROJECT TITLE

SPONSOR

DIRECT AWARDED

Harris, William Thomas

Targeting Smoke Exposure to Improve CFTR Modulator Efficacy

Cystic Fibrosis Foundation

$150,000

Poore, Thomas Spencer

The Intersection Between Atopy and Aspergillus Infection in Cystic Fibrosis

Cystic Fibrosis Foundation

$129,456

Saadoon Alishlash, Ammar

Sickle Cell Trait Mice Aare More Susceptible to Chlorine Exposure and Haptoglobin Improves the Outcomes

National Institute of Environmental Health Sciences/ NIH/DHHS

$125,000

Virella-Lowell, Isabel

A Phase 1 Single Dose Escalation Study Evaluating the Safety and Tolerability of VX 522 in Subjects 18 Years of Age and Older wWith Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy

Vertex Pharmaceuticals, Inc.

$70,420

Virella-Lowell, Isabel

UAB CF Therapeutics Development Center

Cystic Fibrosis Therapeutics Development Network

$268,242

Virella-Lowell, Isabel

UAB Airways Clinical Research Center

American Lung Association

$100,000

PEDIATRIC PULMONOLOGY FELLOWSHIP PROGRAM The UAB Pediatric Pulmonary Fellowship Program strives to train highly competent physician-educators and scientists. Our program provides the clinic knowledge necessary to diagnose and manage pediatric patients with acute and chronic respiratory disorders, including those that are life-threatening. Training in our program is complemented by our UAB Pediatric Pulmonary Center, which is one of five educational programs funded through a competitive federal grant through MCHB and HRSA that focuses on building leadership skills and promoting awareness of childhood respiratory disease. Clinical training is designed to develop the subspecialty resident’s competence in the clinical diagnosis, pathophysiology and medical treatment of respiratory disorders in pediatric patients within an interprofessional healthcare team. Clinical care is provided for children with a remarkable variety of lung diseases and breathing disorders, such as asthma, sleep-disordered breathing, apnea, central hypoventilation, cystic fibrosis, ciliopathies, bronchiectasis, interstitial lung diseases, bronchopulmonary dysplasia, bronchiolitis, pneumonia, chronic respiratory insufficiency, thoracic tumors and congenital lung anomalies. A significant portion of training consists of scholarly activity, during which fellows develop and hone skills necessary to be successful as effective subspecialists, advocates, clinical investigators and pulmonary scientists.

2023–2024 Fellows

Program Directors

Third-Year Fellow Christopher Mertens, M.D. Residency: Pediatrics, The University of Tennessee Health Science Center (UTHSC) Second-Year Fellow Allyson Brown, M.D. Residency: Pediatrics, The Medical University of South Carolina (MUSC)

Brett Turner, M.D. Program Director

Wynton Hoover, M.D. Associate Program Director

Spencer Poore, M.D. Assistant Program Director

Program Coordinator

Kate Hendley

2023 Academic Annual Report

117